OpenURL Connection Search

Select item for more details and to access through your institution.

PRE‐TREATMENT HEMOGLOBIN AND OUTCOME IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH ANTHRACYCLINE CONTAINING CHEMOTHERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 418, doi. 10.1002/hon.88_2631
By:
- Clausen, M.R.;
- Maurer, M.;
- Ulrichsen, S.P.;
- Larsen, T.S.;
- Himmelstrup, B.;
- Ronnov‐Jessen, D.;
- Link, B.;
- Feldman, A.;
- Slager, S.;
- Nowakowski, G.;
- Thompson, C.;
- Pedersen, P.T.;
- Madsen, J.;
- Pedersen, R.S.;
- Gørløv, J.S.;
- Cerhan, J.R.;
- d'Amore, F.
Publication type:
Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R<sup>2</sup>‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
By:
- Nowakowski, G.;
- Willenbacher, W.;
- Greil, R.;
- Larsen, T.S.;
- Patel, K.;
- Jäger, U.;
- Manges, R.F.;
- Trümper, L.;
- Haioun, C.;
- Everaus, H.;
- Kalakonda, N.;
- Knoble, J.;
- Nully Brown, P.;
- Jørgensen, J.M.;
- Cunningham, D.;
- Domper Rubio, N.;
- Casadebaig, M.;
- Manzke, O.;
- Munoz, J.
Publication type:
Article
YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.92_2629
By:
- Leppä, S.;
- Jørgensen, J.;
- Tierens, A.;
- Meriranta, L.;
- Østlie, I.;
- Brown, P.;
- Fagerli, U.;
- Larsen, T.S.;
- Mannisto, S.;
- Munksgaard, L.;
- Maisenhølder, M.;
- Vasala, K.;
- Meyer, P.;
- Jerkeman, M.;
- Björkholm, M.;
- Fluge, Ø.;
- Jyrkkiö, S.;
- Ralfkiaer, E.;
- Spetalen, S.;
- Karjalainen‐Lindsberg, M.
Publication type:
Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R<sup>2</sup>‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
By:
- Nowakowski, G.;
- Willenbacher, W.;
- Greil, R.;
- Larsen, T.S.;
- Patel, K.;
- Jäger, U.;
- Manges, R.F.;
- Trümper, L.;
- Haioun, C.;
- Everaus, H.;
- Kalakonda, N.;
- Knoble, J.;
- Nully Brown, P.;
- Jørgensen, J.M.;
- Cunningham, D.;
- Domper Rubio, N.;
- Casadebaig, M.;
- Manzke, O.;
- Munoz, J.
Publication type:
Article
YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.92_2629
By:
- Leppä, S.;
- Jørgensen, J.;
- Tierens, A.;
- Meriranta, L.;
- Østlie, I.;
- Brown, P.;
- Fagerli, U.;
- Larsen, T.S.;
- Mannisto, S.;
- Munksgaard, L.;
- Maisenhølder, M.;
- Vasala, K.;
- Meyer, P.;
- Jerkeman, M.;
- Björkholm, M.;
- Fluge, Ø.;
- Jyrkkiö, S.;
- Ralfkiaer, E.;
- Spetalen, S.;
- Karjalainen‐Lindsberg, M.
Publication type:
Article
PRE‐TREATMENT HEMOGLOBIN AND OUTCOME IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH ANTHRACYCLINE CONTAINING CHEMOTHERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 418, doi. 10.1002/hon.88_2631
By:
- Clausen, M.R.;
- Maurer, M.;
- Ulrichsen, S.P.;
- Larsen, T.S.;
- Himmelstrup, B.;
- Ronnov‐Jessen, D.;
- Link, B.;
- Feldman, A.;
- Slager, S.;
- Nowakowski, G.;
- Thompson, C.;
- Pedersen, P.T.;
- Madsen, J.;
- Pedersen, R.S.;
- Gørløv, J.S.;
- Cerhan, J.R.;
- d'Amore, F.
Publication type:
Article
DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH-RISK DLBCL: A COMPARISON OF NORDIC CRY-04 AND CHIC STUDIES.
Published in:
Hematological Oncology, 2017, v. 35, p. 199, doi. 10.1002/hon.2438_62
By:
- Leppä, S.;
- Joergensen, J.;
- Nully Brown, P.;
- Fagerli, U.;
- Larsen, T.S.;
- Janes, R.;
- Mannisto, S.;
- Munksgaard, L.;
- Maisenhölder, M.;
- Vasala, K.;
- Meyer, P.;
- Jerkeman, M.;
- Björkholm, M.;
- Fluge, Ø.;
- Jyrkkiö, S.;
- Pedersen, L.M.;
- Eriksson, M.;
- Holte, H.
Publication type:
Article
TREATMENT STRATEGIES AND OUTCOMES IN DIFFUSE LARGE B-CELL LYMPHOMA OF THE ELDERLY: A DANISH POPULATION-BASED COHORT STUDY OF 1,011 PATIENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 100, doi. 10.1002/hon.2437_90
By:
- Juul, M.B.;
- Jensen, P.H.;
- Engberg, H.;
- Wehberg, S.;
- Dessau ‐ Arp, A.;
- Haziri, D.;
- Kristensen, H.B.;
- Baech, J.;
- Schurmann, L.;
- Clausen, M.R.;
- Valentin, R.X.;
- Knudsen, L.M.;
- Munksgaard, L.;
- El ‐ Galaly, T.C.;
- Frederiksen, H.;
- Larsen, T.S.
Publication type:
Article
A PHASE 1/2 STUDY OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20+ TUMORS, RITUXIMAB IN PATIENTS WITH RELAPSED AGGRESSIVE B- OR T-CELL LYMPHOMAS-THE P[R]EBEN STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 423, doi. 10.1002/hon.2440_7
By:
- d'Amore, F.;
- Leppä, S.;
- Larsen, T.S.;
- Brown, P.;
- Relander, T.;
- Mannisto, S.;
- Jørgensen, J.M.;
- Holte, H.;
- Lauritzsen, G.F.;
- Enblad, G.;
- Toldbod, H.
Publication type:
Article
432 Rosiglitazone improves cardiac efficiency and recovery of ventricular function following ischemia in hearts from type 2 diabetic mice
Published in:
2006
By:
- How, O.-J.;
- Larsen, T.S.;
- Hafstad, A.D.;
- Khalid, A.M.;
- Myhre, E.S.P.;
- Severson, D.L.;
- Aasum, E.
Publication type:
Abstract
576 Hearts from type 2 diabetic (db/db) mice are highly sensitive to insulin
Published in:
2004
By:
- Hafstad, A.D.;
- Larsen, T.S.;
- Severson, D.L.;
- Aasum, E.
Publication type:
Abstract

Found: 11